Progressive Retinal Atrophy (PRA-RCD3) in Goldendoodles

Genetic testing panels for dogs often screen for a whole panel of PRA-related mutations at once, since it's efficient to test broadly regardless of documented breed relevance, which is exactly how many owners first encounter rcd3 alongside other subtypes on a single results sheet. A negative or clear result for rcd3 in a Goldendoodle isn't particularly meaningful information one way or the other, since the mutation has no documented pathway into Golden Retriever or Poodle lineage in the first place.

The mutation that is actually well documented and genuinely relevant for this breed is prcd, short for progressive rod-cone degeneration, established specifically in Poodle lines and passed down through that side of the Goldendoodle cross. This is the result worth paying real attention to on a genetic panel — a carrier or affected result for prcd carries real, actionable implications for both individual dog health monitoring and breeding decisions, in a way that an rcd3 result simply doesn't for this particular breed.

This distinction isn't just academic pedantry — it affects what a breeder should actually be screening for, what an owner should actually worry about, and which result on a multi-mutation panel deserves a follow-up conversation with a vet versus which one can be treated as background information without much practical relevance to this specific cross.

Since broad panels test for many mutations at once regardless of breed relevance, knowing which result actually matters for this specific cross avoids unnecessary worry or false reassurance.